What is the equity of Genmab A/S this year?
Genmab A/S has equity of 31.61 B DKK this year.
Genmab A/S Equity 2024
Genmab A/S Equity
31.61 B DKK
Ticker
GMAB.CO
ISIN
DK0010272202
WKN
565131
In 2024, Genmab A/S's equity was 31.61 B DKK, a 15.86% increase from the 27.28 B DKK equity in the previous year.
Genmab A/S Aktienanalyse
What does Genmab A/S do?
Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Genmab A/S's Equity
Genmab A/S's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Genmab A/S's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Genmab A/S's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Genmab A/S's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Genmab A/S’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Genmab A/S stock
What was the equity of Genmab A/S compared to the previous year?
The equity of Genmab A/S has increased/decreased by 15.86% increased compared to the previous year.
What impact does a high equity have on investors of Genmab A/S?
A high equity is advantageous for investors of Genmab A/S as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Genmab A/S?
A low equity can be a risk for investors of Genmab A/S, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Genmab A/S affect the company?
An increase in equity of Genmab A/S can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Genmab A/S affect the company?
A reduction in equity of Genmab A/S can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Genmab A/S?
Some factors that can affect the equity of Genmab A/S include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Genmab A/S so important for investors?
The equity of Genmab A/S is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Genmab A/S take to change the equity?
To change equity, Genmab A/S can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Genmab A/S pay?
Over the past 12 months, Genmab A/S paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Genmab A/S is expected to pay a dividend of 0 DKK.
What is the dividend yield of Genmab A/S?
The current dividend yield of Genmab A/S is .
When does Genmab A/S pay dividends?
Genmab A/S pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Genmab A/S?
Genmab A/S paid dividends every year for the past 0 years.
What is the dividend of Genmab A/S?
For the upcoming 12 months, dividends amounting to 0 DKK are expected. This corresponds to a dividend yield of 0 %.
In which sector is Genmab A/S located?
Genmab A/S is assigned to the 'Health' sector.
Wann musste ich die Aktien von Genmab A/S kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Genmab A/S from 9/12/2024 amounting to 0 DKK, you needed to have the stock in your portfolio before the ex-date on 9/12/2024.
When did Genmab A/S pay the last dividend?
The last dividend was paid out on 9/12/2024.
What was the dividend of Genmab A/S in the year 2023?
In the year 2023, Genmab A/S distributed 0 DKK as dividends.
In which currency does Genmab A/S pay out the dividend?
The dividends of Genmab A/S are distributed in DKK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Genmab A/S stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Genmab A/S
Our stock analysis for Genmab A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genmab A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
